| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| cefepime hydrochloride monohydrate | Injection, powder for | 2378.5 mg | Anticipated | Available | Manufacturing | 30/06/2024 |
| dostarlimab | Injection, intravenous infusion | 500 mg/mL | Anticipated | Available | Unexpected increase in consumer demand | 30/06/2024 |
| atropine sulfate monohydrate | Injection, solution | 1.2 mg/mL | Anticipated | Available | Manufacturing | 28/06/2024 |
| metformin hydrochloride | Tablet, modified release | 500 mg | Current | Unavailable | Manufacturing | 28/06/2024 |
| paliperidone | Tablet, modified release | 6 mg | Current | Limited Availability | Manufacturing | 28/06/2024 |
| pentetic acid | Injection, powder for | 5 mg | Current | Unavailable | Manufacturing | 28/06/2024 |
| midazolam | Injection, solution | 5 mg | Current | Limited Availability | Manufacturing | 28/06/2024 |
| Choriogonadotropin alfa | Injection, solution | 250 microgram | Current | Limited Availability | Unexpected increase in consumer demand | 28/06/2024 |
| perindopril erbumine | Tablet | 8 mg | Current | Limited Availability | Manufacturing | 28/06/2024 |
| rabeprazole sodium | Tablet, enteric coated | 20 mg | Current | Limited Availability | Transport / Logistic issues / Storage capacity issues | 28/06/2024 |
| azithromycin | Injection, powder for | 500 mg | Current | Unavailable | Commercial Changes / Commercial viability | 28/06/2024 |
| atorvastatin calcium trihydrate~amlodipine besilate | Tablet, film coated | 86.751 mg~6.94 mg | Current | Unavailable | Manufacturing | 28/06/2024 |
| esomeprazole magnesium dihydrate | Tablet, enteric coated | 43.5 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 28/06/2024 |
| tadalafil | Tablet, film coated | 5 mg | Current | Limited Availability | Manufacturing | 28/06/2024 |
| duloxetine hydrochloride | Capsule, enteric | 33.65 mg | Current | Limited Availability | Manufacturing | 28/06/2024 |
| duloxetine hydrochloride | Capsule, enteric | 67.3 mg | Current | Unavailable | Manufacturing | 28/06/2024 |
| tadalafil | Tablet | 5 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 28/06/2024 |
| tadalafil | Tablet, film coated | 5 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 28/06/2024 |
| tadalafil | Tablet, film coated | 5 mg | Current | Unavailable | Manufacturing | 28/06/2024 |
| tadalafil | Tablet, film coated | 5 mg | Current | Limited Availability | Manufacturing | 28/06/2024 |
| tadalafil | Tablet, film coated | 5 mg | Current | Unavailable | Manufacturing | 28/06/2024 |
| tadalafil | Tablet, film coated | 5 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 28/06/2024 |
| olmesartan medoxomil~amlodipine besilate | Tablet, film coated | 40 mg~6.935 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 28/06/2024 |
| midodrine hydrochloride | Tablet | 5 mg | Resolved | Available | Manufacturing | 28/06/2024 |
| lurasidone hydrochloride | Tablet, film coated | 40 mg | Current | Unavailable | Manufacturing | 28/06/2024 |
| dasatinib propylene glycol | Tablet, film coated | 58 mg | Current | Unavailable | Manufacturing | 28/06/2024 |
| dasatinib propylene glycol | Tablet, film coated | 81.2 mg | Current | Limited Availability | Manufacturing | 28/06/2024 |
| dasatinib propylene glycol | Tablet, film coated | 23.2 mg | Current | Unavailable | Manufacturing | 28/06/2024 |
| methylphenidate hydrochloride | Tablet, modified release | 36 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 28/06/2024 |
| isoprenaline hydrochloride | Injection, solution | 1 mg | Current | Unavailable | Manufacturing | 28/06/2024 |
| rosuvastatin calcium~ezetimibe | Tablet | 10.4 mg~10 mg | Current | Unavailable | Manufacturing | 28/06/2024 |
| ezetimibe~rosuvastatin calcium | Tablet~Tablet, film coated | 10 mg~20.8 mg | Current | Unavailable | Manufacturing | 28/06/2024 |
| pravastatin sodium | Tablet, uncoated | 40 mg | Current | Limited Availability | Manufacturing | 28/06/2024 |
| trihexyphenidyl (benzhexol) hydrochloride | Tablet, uncoated | 5 mg | Anticipated | Available | Manufacturing | 27/06/2024 |
| donepezil hydrochloride | Tablet, film coated | 10 mg | Current | Limited Availability | Manufacturing | 27/06/2024 |
| propranolol hydrochloride | Tablet, film coated | 40 mg | Current | Limited Availability | Manufacturing | 27/06/2024 |
| clonidine hydrochloride | Tablet, uncoated | 100 microgram | Resolved | Available | Manufacturing | 27/06/2024 |
| doxylamine succinate~paracetamol~codeine phosphate hemihydrate | Tablet, uncoated | 5.1 mg~500 mg~10 mg | Current | Unavailable | Manufacturing | 27/06/2024 |
| simvastatin | Tablet, film coated | 40 mg | Anticipated | Available | Manufacturing | 27/06/2024 |
| rosuvastatin calcium | Tablet, film coated | 41.68 mg | Current | Unavailable | Commercial Changes / Commercial viability | 27/06/2024 |
| fluticasone propionate | Inhalation, pressurised | 125 microgram/actuation | Anticipated | Available | Unexpected increase in consumer demand | 27/06/2024 |
| tobramycin | Inhalation, conventional | 60 mg/mL | Discontinued | Unavailable | Commercial Changes / Commercial viability | 27/06/2024 |
| gliclazide | Tablet, modified release | 30 mg | Current | Unavailable | Manufacturing | 27/06/2024 |
| posaconazole | Tablet, modified release | 100 mg | Current | Limited Availability | Manufacturing | 27/06/2024 |
| lanreotide acetate | Injection, solution | 133.33 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 27/06/2024 |
| sitagliptin hydrochloride monohydrate | Tablet, film coated | 109 mg | Current | Unavailable | Manufacturing | 27/06/2024 |
| sitagliptin hydrochloride monohydrate | Tablet, film coated | 54.5 mg | Current | Unavailable | Manufacturing | 27/06/2024 |
| levothyroxine sodium | Tablet, uncoated | .1 mg | Anticipated | Available | Manufacturing | 27/06/2024 |
| rifampicin | Capsule, hard | 150 mg | Current | Unavailable | Manufacturing | 27/06/2024 |
| fluticasone propionate | Inhalation, pressurised | 50 microgram/actuation | Anticipated | Available | Unexpected increase in consumer demand | 27/06/2024 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Anticipated | Available | Manufacturing | 27/06/2024 |
| prazosin hydrochloride | Tablet, uncoated | 5.476 mg | Anticipated | Available | Unexpected increase in consumer demand | 26/06/2024 |
| duloxetine hydrochloride | Capsule, enteric | 67.3 mg | Anticipated | Available | Manufacturing | 26/06/2024 |
| varenicline tartrate~varenicline tartrate | Tablet, film coated | .85 mg~1.71 mg | Discontinued | Unavailable | Manufacturing | 26/06/2024 |
| varenicline tartrate | Tablet, film coated | 1.71 mg | Discontinued | Unavailable | Manufacturing | 26/06/2024 |
| quetiapine fumarate | Tablet, film coated | 115.12 mg | Anticipated | Available | Manufacturing | 26/06/2024 |
| amlodipine besilate | Tablet | 13.87 mg | Current | Limited Availability | Manufacturing | 26/06/2024 |
| acarbose | Tablet | 100 mg | Current | Limited Availability | Manufacturing | 26/06/2024 |
| cinacalcet hydrochloride | Tablet | 66.127 mg | Current | Unavailable | Manufacturing | 26/06/2024 |
| cinacalcet hydrochloride | Tablet | 99.191 mg | Current | Limited Availability | Manufacturing | 26/06/2024 |
| cinacalcet hydrochloride | Tablet, film coated | 66 mg | Current | Unavailable | Manufacturing | 26/06/2024 |
| cinacalcet hydrochloride | Tablet, film coated | 99 mg | Current | Unavailable | Manufacturing | 26/06/2024 |
| lacosamide | Tablet, film coated | 100 mg | Anticipated | Available | Manufacturing | 26/06/2024 |
| amlodipine besilate~olmesartan medoxomil | Tablet, film coated | 6.935 mg~20 mg | Current | Unavailable | Manufacturing | 26/06/2024 |
| gliclazide | Tablet, uncoated | 80 mg | Anticipated | Available | Unexpected increase in consumer demand | 26/06/2024 |
| methylphenidate hydrochloride | Tablet, modified release | 27 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 26/06/2024 |
| methylphenidate hydrochloride | Tablet, modified release | 18 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 26/06/2024 |
| methylphenidate hydrochloride | Tablet, modified release | 54 mg | Discontinued | Reduction in supply until supply is exhausted | Manufacturing | 26/06/2024 |
| mycophenolate mofetil | Suspension | 200 mg/mL | Current | Limited Availability | Manufacturing | 26/06/2024 |
| cisplatin | Injection, solution | 1 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 26/06/2024 |
| rifampicin | Capsule, hard | 300 mg | Resolved | Available | Manufacturing | 26/06/2024 |
| phytomenadione | Injection, solution | 10 mg/mL | Current | Limited Availability | Product recall | 26/06/2024 |
| oxycodone hydrochloride | Capsule, hard | 10 mg | Current | Limited Availability | Commercial Changes / Commercial viability | 26/06/2024 |
| metformin hydrochloride | Tablet, film coated | 1000 mg | Anticipated | Available | Manufacturing | 26/06/2024 |
| baclofen | Tablet, uncoated | 10 mg | Current | Unavailable | Manufacturing | 26/06/2024 |
| lisinopril dihydrate | Tablet, uncoated | 10.89 mg | Current | Unavailable | Manufacturing | 25/06/2024 |
| colestyramine | Powder, oral | 850 mg/g | Resolved | Available | Manufacturing | 25/06/2024 |
| trandolapril | Capsule | .5 mg | Resolved | Available | Manufacturing | 25/06/2024 |
| mycophenolate mofetil | Capsule | 250 mg | Resolved | Available | Manufacturing | 25/06/2024 |
| morphine hydrochloride trihydrate | Oral Liquid, solution | 1 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 25/06/2024 |
| morphine hydrochloride trihydrate | Oral Liquid, solution | 5 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 25/06/2024 |
| morphine hydrochloride trihydrate | Oral Liquid, solution | 10 mg/mL | Current | Unavailable | Commercial Changes / Commercial viability | 25/06/2024 |
| prochlorperazine maleate | Tablet | 5 mg | Current | Limited Availability | Manufacturing | 25/06/2024 |
| prochlorperazine maleate | Tablet | 5 mg | Anticipated | Available | Commercial Changes / Commercial viability | 25/06/2024 |
| ropivacaine hydrochloride | Injection, solution | 7.5 mg/mL | Current | Unavailable | Manufacturing | 25/06/2024 |
| zoledronic acid monohydrate | Injection, concentrated | .8528 mg/mL | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 25/06/2024 |
| quetiapine fumarate | Tablet, modified release | 460.52 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 25/06/2024 |
| duloxetine hydrochloride | Capsule, enteric | 33.66 mg | Current | Unavailable | Unexpected increase in consumer demand | 25/06/2024 |
| lisinopril dihydrate | Tablet, uncoated | QS | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 25/06/2024 |
| pantoprazole sodium sesquihydrate | Tablet, enteric coated | 45.4 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 25/06/2024 |
| temozolomide | Capsule, hard | 5 mg | Current | Unavailable | Manufacturing | 25/06/2024 |
| pregabalin | Capsule, hard | 75 mg | Current | Unavailable | Commercial Changes / Commercial viability | 25/06/2024 |
| pregabalin | Capsule, hard | 300 mg | Current | Unavailable | Manufacturing | 25/06/2024 |
| voriconazole | Injection, powder for | 200 mg | Current | Unavailable | Manufacturing | 25/06/2024 |
| emtricitabine~tenofovir disoproxil maleate | Tablet, film coated | 200 mg~300 mg | Current | Limited Availability | Manufacturing | 25/06/2024 |
| tenofovir disoproxil fumarate~emtricitabine | Tablet, film coated | 300 mg~200 mg | Current | Unavailable | Commercial Changes / Commercial viability | 25/06/2024 |
| hydroxocobalamin acetate | Injection, solution | 1.044 mg | Resolved | Available | Manufacturing | 25/06/2024 |
| hydrochlorothiazide~olmesartan medoxomil | Tablet | 25 mg~40 mg | Current | Limited Availability | Manufacturing | 25/06/2024 |
| dasatinib | Tablet, film coated | 50 mg | Current | Unavailable | Manufacturing | 25/06/2024 |
| dasatinib | Tablet, film coated | 70 mg | Anticipated | Available | Commercial Changes / Commercial viability | 25/06/2024 |
| atomoxetine hydrochloride | Capsule, hard | 45.5 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 25/06/2024 |
| latanoprost | Eye Drops, solution | .05 mg/mL | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 25/06/2024 |
| olanzapine | Tablet, uncoated | 7.5 mg | Current | Unavailable | Manufacturing | 25/06/2024 |
| nebivolol hydrochloride | Tablet | 5.45 mg | Current | Unavailable | Manufacturing | 25/06/2024 |
| bendamustine hydrochloride monohydrate | Injection, powder for | 25 mg | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 25/06/2024 |
| chloramphenicol | Eye Drops | 5 mg/mL | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 25/06/2024 |
| midazolam maleate | Solution | 6.8 mg | Resolved | Available | Manufacturing | 25/06/2024 |
| indometacin | Capsule, hard | 25 mg | Current | Limited Availability | Manufacturing | 25/06/2024 |
| sugammadex sodium | Injection | 217.6 mg | Current | Unavailable | Manufacturing | 25/06/2024 |
| insulin | Injection, suspension | 100 IU/mL | Resolved | Available | Manufacturing | 25/06/2024 |
| Teriparatide | Injection, solution | 250 microgram/mL | Resolved | Available | Manufacturing | 25/06/2024 |
| amikacin | Injection, solution | 500 mg | Resolved | Available | Manufacturing | 25/06/2024 |
| azithromycin dihydrate | Tablet, film coated | 628.93 mg | Anticipated | Available | Manufacturing | 25/06/2024 |
| flecainide acetate | Tablet, uncoated | 100 mg | Current | Limited Availability | Manufacturing | 25/06/2024 |
| tobramycin | Inhalation, conventional | 60 mg/mL | Current | Unavailable | Manufacturing | 25/06/2024 |
| oxycodone hydrochloride | Capsule, hard | 20 mg | Resolved | Available | Commercial Changes / Commercial viability | 25/06/2024 |
| oxycodone hydrochloride | Capsule, hard | 5 mg | Resolved | Available | Commercial Changes / Commercial viability | 25/06/2024 |
| tobramycin | Injection, solution | 40 mg/mL | Resolved | Available | Manufacturing | 25/06/2024 |
| methylphenidate hydrochloride | Tablet, modified release | 18 mg | Current | Limited Availability | Manufacturing | 25/06/2024 |
| amlodipine besilate | Tablet, uncoated | 6.94 mg | Current | Limited Availability | Manufacturing | 24/06/2024 |
| sildenafil citrate | Tablet, film coated | 28.1 mg | Current | Unavailable | Transport / Logistic issues / Storage capacity issues | 24/06/2024 |
| aciclovir sodium dihydrate | Injection, powder for | 314.4 mg | Current | Limited Availability | Unexpected increase in consumer demand | 24/06/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 24/06/2024 |
| ezetimibe | Tablet, uncoated | 10 mg | Resolved | Available | Manufacturing | 24/06/2024 |
| lacosamide | Tablet, film coated | 50 mg | Resolved | Available | Manufacturing | 24/06/2024 |
| morphine sulfate pentahydrate | Tablet, film coated | 10 mg | Discontinued | Unavailable | Commercial Changes / Commercial viability | 24/06/2024 |
| olanzapine | Injection, powder for | 10 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 24/06/2024 |
| famotidine | Tablet, film coated | 40 mg | Current | Unavailable | Manufacturing | 24/06/2024 |
2024年7月2日